Alliance Health Networks, a developer of condition-specific social networks, announced that it raised $11 million from investors.
The company said it will use the funds to expand its platforms, including its mobile platform for consumers seeking health-related social networking.
The New York City-based company owns a portfolio of distinct social networking sites that serve 750,000 registered members across 37 health conditions.
Alliance Health’s sites enable patients and caregivers to form relationships, engage in conversations, share treatments and comment on services and products, according to the release.
Here’s a roundup of the latest dealflow and investment news:
- Teleflex announces $250 million public offering
Teleflex Inc. (NYSE:TFX) announced a registered public offering of $250 million of senior subordinated unsecured notes due 2021. The notes will be guaranteed by several Teleflex subsidiaries, and the interest rate and other terms of the notes will be determined at pricing. The Limerick, Pa.-based medical device maker announced that it will use the funds to prepay $125 million in borrowings under its credit facilities, and the remainder for "general corporate purposes," according to the SEC filing.
- Sapiens Brain Steering wins $18.7 million
Sapiens Brain Steering Stimulation GmbH announced $18.7 million raised in a Series A financing round. The company plans to use the funds to develop a novel brain stimulation system, according to the release.
- ADVANCE Medical announces $6 million in Series A round
ADVANCE Medical announced that it raised $6 million in a Series A financing round, led by Venrock, the Rockefeller family’s venture capital arm. ADVANCE partners with medical technology firms to commercialize products in Latin America.
- Kensey Nash announces revolving credit facility
Kensey Nash Corp. (NSDQ:KNSY) announced that it entered into a $35 million unsecured revolving credit facility with Wells Fargo Bank, National Assn. The facility will mature in 2014. The Exton, Pa-based cop many recently acquired the Norian product line from Synthes Inc.’s (VTX:SYST).